Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,007 | 110 | 63.5% |
| Consulting Fee | $24,046 | 14 | 12.8% |
| Travel and Lodging | $19,934 | 110 | 10.6% |
| Food and Beverage | $12,181 | 321 | 6.5% |
| Honoraria | $12,116 | 10 | 6.5% |
| Education | $62.07 | 4 | 0.0% |
| Long term medical supply or device loan | $59.94 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $139,563 | 347 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $19,345 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $17,101 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $8,990 | 35 | $0 (2024) |
| Amgen Inc. | $631.31 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $325.46 | 4 | $0 (2023) |
| Abbott Laboratories | $319.86 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $267.77 | 19 | $0 (2022) |
| Lilly USA, LLC | $160.89 | 8 | $0 (2024) |
| Corcept Therapeutics | $159.02 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,430 | 63 | Novo Nordisk Inc ($5,680) |
| 2023 | $30,189 | 85 | Novo Nordisk Inc ($22,244) |
| 2022 | $64,334 | 195 | Novo Nordisk Inc ($53,885) |
| 2021 | $80,454 | 227 | Novo Nordisk Inc ($57,754) |
All Payment Transactions
570 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.80 | General |
| 12/04/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $104.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $101.81 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $30.56 | General |
| 10/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.32 | General |
| 10/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $663.00 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 325 | 440 | $110,130 | $25,761 |
| 2022 | 4 | 331 | 459 | $89,060 | $24,860 |
| 2021 | 4 | 331 | 489 | $83,865 | $30,362 |
| 2020 | 6 | 374 | 501 | $84,250 | $24,152 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 95 | 145 | $39,875 | $9,241 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 73 | $20,075 | $4,834 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 35 | 46 | $16,100 | $4,683 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 79 | $15,010 | $2,967 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 81 | $15,390 | $2,936 | 19.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 16 | $3,680 | $1,100 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 89 | 134 | $30,280 | $8,484 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 126 | 196 | $29,245 | $7,860 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 36 | 44 | $13,120 | $4,460 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 45 | $8,030 | $1,962 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 27 | $7,245 | $1,830 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 13 | $1,140 | $263.96 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 143 | 225 | $41,625 | $14,597 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 117 | 168 | $21,000 | $7,678 | 36.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 56 | 78 | $19,890 | $7,615 | 38.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 15 | 18 | $1,350 | $472.86 | 35.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 152 | 236 | $43,660 | $11,770 | 27.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 49 | 63 | $16,065 | $4,612 | 28.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 50 | 57 | $8,310 | $3,209 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 79 | 96 | $12,000 | $3,044 | 25.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 33 | 38 | $3,390 | $1,364 | 40.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 11 | 11 | $825.00 | $153.54 | 18.6% |
About Lisa Coco, N.P
Lisa Coco, N.P is a Nurse Practitioner healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841203726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Coco, N.P has received a total of $187,407 in payments from pharmaceutical and medical device companies, with $12,430 received in 2024. These payments were reported across 570 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,007).
As a Medicare-enrolled provider, Coco has provided services to 1,361 Medicare beneficiaries, totaling 1,889 services with total Medicare billing of $105,135. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Philadelphia, PA
- Active Since 08/14/2006
- Last Updated 03/26/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1841203726
Products in Payments
- Rybelsus (Drug) $46,434
- Ozempic (Drug) $40,798
- RYBELSUS (Drug) $36,322
- FARXIGA (Drug) $17,101
- GVOKE PFS (Drug) $10,841
- GVOKE HYPOPEN (Drug) $8,465
- SOLIQUA 100/33 (Biological) $4,202
- TOUJEO (Biological) $3,563
- EVENITY (Biological) $416.20
- Kerendia (Drug) $325.46
- Vascepa (Drug) $267.77
- FREESTYLE LIBRE 3 (Device) $235.34
- TEPEZZA (Biological) $178.41
- TZIELD (Biological) $163.44
- Korlym (Drug) $159.02
- MOUNJARO (Drug) $96.56
- AFREZZA (Drug) $74.28
- FREESTYLE INSULINX (Device) $59.94
- MYALEPT (Drug) $46.29
- Tymlos (Drug) $41.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Philadelphia
Patricia Mangan, Crnp, CRNP
Nurse Practitioner — Payments: $307,094
Elisabeth Baidal, Anp, ANP
Nurse Practitioner — Payments: $150,546
Suzanne Mcgettigan, Crnp, CRNP
Nurse Practitioner — Payments: $94,673
Faith Mutale, Crnp, CRNP
Nurse Practitioner — Payments: $53,751
Carolyn Grande, Crnp, CRNP
Nurse Practitioner — Payments: $53,718
Frances Rogers, Crnp, CRNP
Nurse Practitioner — Payments: $37,898